F-star Therapeutics, Inc.

Just over a decade after Simon Westbrook bought a promising non-addictive he had developed from former employer Pfizer Inc. , the company he formed – Levicept Ltd – has posted promising mid-stage da

Roughly a month after suffering a setback in its oncology franchise with the market withdrawal of a drug for lung cancer, Takeda Pharmaceutical Co. Ltd. got some welcome news with the approval of a

Tessellate Bio, a preclinical stage biotech company with a focus on novel synthetic lethality approaches, has emerged from stealth with an initial €8m in seed funding from two European venture capital

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Takeda, F-star Sign Joint Research Pact